DRUG · Unmapped registry intervention
LY900014
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes
NCT03952143
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Insulin Lispro
Normalized identity: insulin lisproView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Insulin Glargine
Normalized identity: insulin glargineView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Insulin Degludec
Normalized identity: insulin degludecView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
LY900014DRUG
Insulin LisproDRUG · verified · RxNorm: insulin lispro
Insulin GlargineDRUG · verified · RxNorm: insulin glargine
Insulin DegludecDRUG · verified · RxNorm: insulin degludec
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03952143 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.